Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-54947
J Pharmacol Sci 2018 May 01;1371:93-97. doi: 10.1016/j.jphs.2018.01.010.
Show Gene links Show Anatomy links

The neurosteroid allopregnanolone sulfate inhibits Nav1.3 α subunit-containing voltage-gated sodium channels, expressed in Xenopus oocytes.

Horishita T , Yanagihara N , Ueno S , Okura D , Horishita R , Minami T , Ogata Y , Sudo Y , Uezono Y , Kawasaki T .


???displayArticle.abstract???
The neurosteroid allopregnanolone has potent analgesic effects, and its potential use for neuropathic pain is supported by recent reports. However, the analgesic mechanisms are obscure. The voltage-gated sodium channels (Nav) α subunit Nav1.3 is thought to play an essential role in neuropathic pain. Here, we report the effects of allopregnanolone sulfate (APAS) on sodium currents (INa) in Xenopus oocytes expressing Nav1.3 with β1 or β3 subunits. APAS suppressed INa of Nav1.3 with β1 and β3 in a concentration-dependent manner (IC50 values; 75 and 26 μmol/L). These results suggest the possible importance of Nav1.3 inhibition for the analgesic mechanisms of allopregnanolone.

???displayArticle.pubmedLink??? 29773519
???displayArticle.link??? J Pharmacol Sci


Species referenced: Xenopus
Genes referenced: nav1


???attribute.lit??? ???displayArticles.show???